Innovating for a healthier future
We are discovering new therapeutics with rare & novel cannabinoids
Advancing Cannabinoid Research for a New Generation of Therapeutics
After decades of restriction, cannabinoids have emerged as a frontier of discovery - interacting with the Endocannabinoid system, an abundant GPCR network; these neuromodulating small molecules can transform human health and wellness.
Merging rational-based drug design with artificial intelligence, FloraWorks' discovery platform Paragon™ will accelerate our understanding of cannabinoids and their physiological responses, leading to actionable nutraceuticals and new drug target identification.
The first and only clinically validated cannabinoid to improve sleep
Learn how you can leverage clinically backed claims to transform your brand into a market frontrunner and disrupt the OTC sleep aid market!
TruCBN™ in the news
Explore how TruCBN™ is redefining sleep wellness with clinically validated research, making headlines as the trusted, scientifically-backed choice for better rest.
Purchase minor cannabinoids
As the leader in minor cannabinoid supply and scientific research, we offer a diverse range of high-quality cannabinoids to meet the needs of a rapidly evolving industry. Explore our selection, including TruCBN™
The frontier of opportunity
We believe in the power of collaboration. At FloraWorks, we accelerate positive health impacts by coming together with academia and institutions worldwide.
Join us at the frontier of discovery to unlock a deeper understanding of the endocannabinoid system and the impact cannabinoids and cannabinoid-inspired compounds can have on improving the lives of millions.
FloraWorks news and events
CBN vs. CBD: Unveiling the Potential for Product Innovation
TruCBN™: A Breakthrough in Better Sleep
Building Trust in Cannabinoids: Insights from FloraWorks CEO on The Dime Podcast
Stay ahead in the world of cannabinoid science
Join our exclusive email list for the latest insights and breakthroughs.
